These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11972795)

  • 1. OLIG-1 and 2 gene expression and oligodendroglial tumours.
    Hoang-Xuan K; Aguirre-Cruz L; Mokhtari K; Marie Y; Sanson M
    Neuropathol Appl Neurobiol; 2002 Apr; 28(2):89-94. PubMed ID: 11972795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells.
    Bouvier C; Bartoli C; Aguirre-Cruz L; Virard I; Colin C; Fernandez C; Gouvernet J; Figarella-Branger D
    J Neurosurg; 2003 Aug; 99(2):344-50. PubMed ID: 12924709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors.
    Lu QR; Park JK; Noll E; Chan JA; Alberta J; Yuk D; Alzamora MG; Louis DN; Stiles CD; Rowitch DH; Black PM
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10851-6. PubMed ID: 11526205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion.
    Marucci G; Di Oto E; Farnedi A; Panzacchi R; Ligorio C; Foschini MP
    Hum Pathol; 2012 Mar; 43(3):374-80. PubMed ID: 21835431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas.
    Riemenschneider MJ; Koy TH; Reifenberger G
    Acta Neuropathol; 2004 Mar; 107(3):277-82. PubMed ID: 14730454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OLIG2 as a specific marker of oligodendroglial tumour cells.
    Marie Y; Sanson M; Mokhtari K; Leuraud P; Kujas M; Delattre JY; Poirier J; Zalc B; Hoang-Xuan K
    Lancet; 2001 Jul; 358(9278):298-300. PubMed ID: 11498220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the bHLH transcription factors Olig1 and Olig2 in brain tumors.
    Aguirre-Cruz L; Mokhtari K; Hoang-Xuan K; Marie Y; Criniere E; Taillibert S; Lopes M; Delattre JY; Sanson M
    J Neurooncol; 2004 May; 67(3):265-71. PubMed ID: 15164981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical comparative analysis of GFAP, MAP - 2, NOGO - A, OLIG - 2 and WT - 1 expression in WHO 2016 classified neuroepithelial tumours and their prognostic value.
    Schwab DE; Lepski G; Borchers C; Trautmann K; Paulsen F; Schittenhelm J
    Pathol Res Pract; 2018 Jan; 214(1):15-24. PubMed ID: 29258767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas.
    Schäfer S; Behling F; Skardelly M; Koch M; Ott I; Paulsen F; Tabatabai G; Schittenhelm J
    Neuropathol Appl Neurobiol; 2018 Feb; 44(2):207-223. PubMed ID: 29053887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
    Ligon KL; Alberta JA; Kho AT; Weiss J; Kwaan MR; Nutt CL; Louis DN; Stiles CD; Rowitch DH
    J Neuropathol Exp Neurol; 2004 May; 63(5):499-509. PubMed ID: 15198128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas.
    Ohnishi A; Sawa H; Tsuda M; Sawamura Y; Itoh T; Iwasaki Y; Nagashima K
    J Neuropathol Exp Neurol; 2003 Oct; 62(10):1052-9. PubMed ID: 14575240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection.
    Lu QR; Sun T; Zhu Z; Ma N; Garcia M; Stiles CD; Rowitch DH
    Cell; 2002 Apr; 109(1):75-86. PubMed ID: 11955448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens.
    Gelpi E; Ambros IM; Birner P; Luegmayr A; Drlicek M; Fischer I; Kleinert R; Maier H; Huemer M; Gatterbauer B; Anton J; Rössler K; Budka H; Ambros PF; Hainfellner JA
    Mod Pathol; 2003 Jul; 16(7):708-15. PubMed ID: 12861068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olig bHLH proteins interact with homeodomain proteins to regulate cell fate acquisition in progenitors of the ventral neural tube.
    Sun T; Echelard Y; Lu R; Yuk DI; Kaing S; Stiles CD; Rowitch DH
    Curr Biol; 2001 Sep; 11(18):1413-20. PubMed ID: 11566099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Common mechanism underlying oligodendrocyte development and oligodendrogliomagenesis].
    Kondo T
    Brain Nerve; 2009 Jul; 61(7):741-51. PubMed ID: 19618851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An 'oligarchy' rules neural development.
    Rowitch DH; Lu QR; Kessaris N; Richardson WD
    Trends Neurosci; 2002 Aug; 25(8):417-22. PubMed ID: 12127759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Carbonic Anhydrase-9 Expression Identifies a Subset of 1p/19q Co-Deletion and Favorable Prognosis in Oligodendroglioma.
    Sathornsumetee S; Cheunsuchon P; Sangruchi T
    World Neurosurg; 2016 Jul; 91():518-523.e1. PubMed ID: 26960282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic expression of basic helix-loop-helix Olig family members: implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3.
    Takebayashi H; Yoshida S; Sugimori M; Kosako H; Kominami R; Nakafuku M; Nabeshima Y
    Mech Dev; 2000 Dec; 99(1-2):143-8. PubMed ID: 11091082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification.
    Mokhtari K; Paris S; Aguirre-Cruz L; Privat N; Crinière E; Marie Y; Hauw JJ; Kujas M; Rowitch D; Hoang-Xuan K; Delattre JY; Sanson M
    Neuropathol Appl Neurobiol; 2005 Feb; 31(1):62-9. PubMed ID: 15634232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.